Answers are grounded in this paper and cite their sources.
This narrative review examines fetal brain development in relation to several biologically distinct prenatal exposures: maternal infection, direct congenital infection, maternal immune activation (MIA), placental and fetal inflammatory responses, and neonatal or postnatal infection. These exposures should not be treated as interchangeable because they differ in timing, route of exposure, and strength of evidence for later neuro-developmental outcomes. We therefore distinguish direct pathogen-mediated fetal injury from indirect immune-mediated pathways and separately consider structural congenital abnormalities, neonatal brain injury, early developmental phenotypes, behavioral symptoms, and later psychiatric diagnoses. Particular emphasis is placed on the limitations of causal inference in human observational studies and on the complementary, but non-equivalent, role of experimental MIA models. Prevention and monitoring recommendations are restricted to established maternal and neonatal benefits and to clinically indicated fetal or neonatal assessment. The review emphasizes the importance of timely interventions and the need for comprehensive maternal care as well as public health initiatives to mitigate the adverse effects of maternal infections on fetal brain development.
No takes yet. Share an insight, caveat, or question.
Atafo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: